1. Home
  2. VERU vs WKEY Comparison

VERU vs WKEY Comparison

Compare VERU & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • WKEY
  • Stock Information
  • Founded
  • VERU 1971
  • WKEY 1999
  • Country
  • VERU United States
  • WKEY Switzerland
  • Employees
  • VERU N/A
  • WKEY N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • VERU Health Care
  • WKEY Technology
  • Exchange
  • VERU Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • VERU 94.5M
  • WKEY 86.9M
  • IPO Year
  • VERU 1990
  • WKEY N/A
  • Fundamental
  • Price
  • VERU $0.60
  • WKEY $6.70
  • Analyst Decision
  • VERU Strong Buy
  • WKEY Strong Buy
  • Analyst Count
  • VERU 2
  • WKEY 1
  • Target Price
  • VERU $4.00
  • WKEY $4.00
  • AVG Volume (30 Days)
  • VERU 2.8M
  • WKEY 251.7K
  • Earning Date
  • VERU 08-07-2025
  • WKEY 07-15-2025
  • Dividend Yield
  • VERU N/A
  • WKEY N/A
  • EPS Growth
  • VERU N/A
  • WKEY N/A
  • EPS
  • VERU N/A
  • WKEY N/A
  • Revenue
  • VERU $16,886,419.00
  • WKEY $11,875,000.00
  • Revenue This Year
  • VERU N/A
  • WKEY $18.18
  • Revenue Next Year
  • VERU N/A
  • WKEY $112.51
  • P/E Ratio
  • VERU N/A
  • WKEY N/A
  • Revenue Growth
  • VERU 134.43
  • WKEY N/A
  • 52 Week Low
  • VERU $0.45
  • WKEY $1.61
  • 52 Week High
  • VERU $1.42
  • WKEY $14.00
  • Technical
  • Relative Strength Index (RSI)
  • VERU 51.69
  • WKEY 53.41
  • Support Level
  • VERU $0.57
  • WKEY $6.21
  • Resistance Level
  • VERU $0.73
  • WKEY $7.12
  • Average True Range (ATR)
  • VERU 0.05
  • WKEY 0.57
  • MACD
  • VERU -0.01
  • WKEY -0.04
  • Stochastic Oscillator
  • VERU 29.41
  • WKEY 75.82

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: